Singh, Jasvinder A. http://orcid.org/0000-0003-3485-0006
Article History
First Online: 12 August 2019
Competing interests
: J.A.S. declares that he has received consultant fees from Crealta/Horizon, Medisys, Fidia, UBM LLC, Medscape, WebMD, Clinical Care options, Clearview Healthcare Partners, Putnam Associates, Spherix, the NIH and the American College of Rheumatology; owns stock options in Amarin pharmaceuticals and Viking therapeutics; is a member of the executive of OMERACT, an organization that develops outcome measures in rheumatology and receives arms-length funding from 36 companies; serves on the FDA Arthritis Advisory Committee; is a member of the Veterans Affairs Rheumatology Field Advisory Committee; is the editor and the Director of the UAB Cochrane Musculoskeletal Group Satellite Center on Network Meta-analysis; and previously served as a member of the following committees: member of the American College of Rheumatology’s (ACR) Annual Meeting Planning Committee (AMPC) and Quality of Care Committees, Chair of the ACR Meet-the-Professor, Workshop and Study Group Subcommittee and co-chair of the ACR Criteria and Response Criteria subcommittee.